0 – Page 3 of 5 – Cambridge Enterprise

Horizon successfully completes pilot human gene-editing programme with leading pharma

PneumaCare wins two Medical Futures Innovation Awards

Researchers partner with Morgan AM&T to develop nanotechnology

More than 100 research reagents now available for licensing

CamSemi moves into LED lighting field

Consortium of multinationals to back laminate recycling plant

Development of next generation solar technology moves forward

Enecsys secures £25m investment

Leadership changes at Cambridge Enterprise

New hope for treatment of recurrent miscarriage

Sentinel Oncology awarded Eurostars grant for research and development

Astex starts Phase I study on new anti-cancer compound